Kolexia
Djaileb Loic
Médecine nucléaire
Hôpital Nord Grenoble
La Tronche, France
85 Activités
729 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Cardiomyopathies Maladie des artères coronaires Lymphomes Diabète de type 2 Ischémie Ischémie myocardique Métastase tumorale Diabète

Industries

Siemens Healthcare
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Regional CZT myocardial perfusion reserve for the detection of territories with simultaneously impaired CFR and IMR in patients without obstructive coronary artery disease: a pilot study.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology   22 janvier 2024
Differences and Common Ground in Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   18 janvier 2024
Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction.
Microcirculation (New York, N.Y. : 1994)   04 janvier 2024
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices.
EJNMMI radiopharmacy and chemistry   26 octobre 2023
TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies.
EJNMMI radiopharmacy and chemistry   19 octobre 2023
Presurgical Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
European urology   21 juillet 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
Radiology   13 juillet 2023
PDF PSMA PET imaging improves accuracy of predicting prostate cancer recurrence
Medical X Press   01 juillet 2023
PSMA PET imaging improves accuracy of predicting prostate cancer recurrence
Medical X Press   01 juillet 2023